2003D-0570 - Guidance for Industry: GUIDANCE FOR THE CLINICAL EVALUATION OF WEIGHT- CONTROL DRUGS; Availability

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC3
  



  

  

  



  

  
Submitter : 
  

  
Dr. George Bray
  

  
Date & Time: 
  

  
04/19/2004 03:04:23
  



  

  
Organization : 
  

  
Pennington Biomedical Research Center
  



  

  
Academia
  


  

  
Category : 
  


  

  
Issue Areas/Comments 
  


  

  



  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 We view the procedures for evaluating a drug in the treatment of obesity as an opportunity to demonstrate the efficacy of the drug and its high level of safety; considering the population in which it will be used, we also view this process as a basis for developing information about the use of a drug by physicians in the practice of medicine and the care of their patients.